Fasting glucose and insulin levels were measured at baseline. HOMA-IR was used to estimated IR. During follow-up, 211 participants developed AD, with 71 individuals developing it within 3 years. Following 3 years, the risk was no longer increased, suggesting that insulin metabolism influences the risk of AD only within 3 years. This evidence concerns the gene INS and Alzheimer disease.